$3.44
0.12.99%
At close: -
$3.48
0.041.16%
After Hours: Nov 22, 6:54 PM EDT
Comments
Loading...
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock, Earnings Estimates, EPS, And Revenue
Ironwood Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 13
EPS Estimate
$0.120
Quarterly Revenue Estimate
$95.7M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$378.4M
Analyze the earnings history of Ironwood Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Ironwood Pharmaceuticals (IRWD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $0.02 | $0.08 | -75.0 % |
| Jun 2024 | 2024-08-08 | $0.01 | $0.15 | -93.3 % |
| Mar 2024 | 2024-05-09 | $-0.02 | $0.20 | -110.0 % |
| Dec 2023 | 2024-02-15 | $0 | $0.21 | -100.0 % |
Ironwood Pharmaceuticals (IRWD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $94.40M | $107.00M | -11.8 % |
| Mar 2024 | 2024-05-09 | $74.88M | $106.30M | -29.6 % |
| Dec 2023 | 2024-02-15 | $117.55M | $117.48M | 0.06 % |
| Sep 2023 | 2023-11-09 | $113.74M | $112.89M | 0.75 % |
FAQ
When is Ironwood Pharmaceuticals (NASDAQ:IRWD) reporting earnings?
Ironwood Pharmaceuticals (IRWD) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Ironwood Pharmaceuticals (NASDAQ:IRWD)?
The Actual EPS was $0.02, which missed the estimate of $0.08.
What were Ironwood Pharmaceuticals’s (NASDAQ:IRWD) revenues?
The Actual Revenue was $91.6M, which beat the estimate of $91.3M.
Browse earnings estimates, EPS, and revenue on all stocks.